Nanexa AB (publ)

Stockholm Stock Exchange NANEXA.ST

Nanexa AB (publ) Market Capitalization on January 14, 2025: USD 26.84 M

Nanexa AB (publ) Market Capitalization is USD 26.84 M on January 14, 2025, a 73.89% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Nanexa AB (publ) 52-week high Market Capitalization is USD 35.88 M on December 05, 2024, which is 33.66% above the current Market Capitalization.
Nanexa AB (publ) 52-week low Market Capitalization is USD 7.48 M on April 26, 2024, which is -72.12% below the current Market Capitalization.
Nanexa AB (publ) average Market Capitalization for the last 52 weeks is USD 16.13 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Stockholm Stock Exchange: NANEXA.ST

Nanexa AB (publ)

CEO	Mr. David Westberg
IPO Date	June 17, 2015
Location	Sweden
Headquarters	Virdings AllE 32B
Employees	19
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

Key trends

Past 5 years